Norlichexanthone isolated from fungus P16 promotes the secretion and expression of adiponectin in cultured ST-13 adipocytes

Medicinal Chemistry

Volumn 7, Issue 4, 2011, Pages 250-256

  Ikeda, Megumi ^a   Kurotobi, Yoshiko ^a   Namikawa, Aiko ^a   Kuranuki, Sachi ^a   Matsuura, Nobuyasu ^b   Sato, Mayumi ^c   Igarashi, Yasuhiro ^d   Nakamura, Teiji ^a   Oikawa, Tsutomu ^a  

^a KANAGAWA UNIVERSITY OF HUMAN SERVICES   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d TOYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Adipogenesis; Adiponectin; Lifestyle related diseases; Norlichexanthone; Peroxisome proliferator activated receptor ; ST 13 preadipocyte; Thiazolidinedione; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; BUTANOL; DACTINOMYCIN; FATTY ACID BINDING PROTEIN; FUNGAL EXTRACT; MESSENGER RNA; NORLICHEXANTHONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL STRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; FUNGAL STRAIN; FUNGUS CULTURE; GENE EXPRESSION REGULATION; HYPOTHESIS; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; RECEPTOR UPREGULATION; WESTERN BLOTTING;

ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; ANIMALS; AZO COMPOUNDS; CELL LINE; COLORING AGENTS; DACTINOMYCIN; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACID-BINDING PROTEINS; FUNGI; HYPOGLYCEMIC AGENTS; LIFE STYLE; MICE; MOLECULAR TARGETED THERAPY; PPAR GAMMA; PROTEIN SYNTHESIS INHIBITORS; TRANSCRIPTION, GENETIC; XANTHONES;

EID: 79959346467     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340611796150950     Document Type: Article

References (50)

1. Tsao, T.S.; Lodish, H.F.; Fruebis, J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur. J. Pharmacol. 2002, 440, 213-21. (Pubitemid 34458025)
2. Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006, 116, 1784-92. (Pubitemid 44033298)
3. Scherer, P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes, 2006, 55, 1537-45. (Pubitemid 44324105)
4. Tontonoz, P.; Spiegelman, B.M. Fat and beyond: the diverse biology of PPARγ. Annu. Rev. Biochem. 2008, 77, 289-312.
5. Arita, Y.; Kihara, S.; Ouchi, N.; Takahashi, M.; Maeda, K.; Miyagawa, J.; Hotta, K.; Shimomura, I.; Nakamura, T.; Miyaoka, K.; Kuriyama, H.; Nishida, M.; Yamashita, S.; Okubo, K.; Matsubara, K.; Muraguchi, M.; Ohmoto, Y.; Funahashi, T.; Matsuzawa, Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257, 79-83. (Pubitemid 29299050)
6. Weyer, C.; Funahashi, T.; Tanaka, S.; Hotta, K.; Matsuzawa, Y.; Pratley, R.E.; Tataranni, P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86, 1930-5. (Pubitemid 32472900)
7. Hu, E.; Liang, P.; Spiegelman, B.M. AdipoQ is a novel adiposespecific gene dysregulated in obesity. J. Biol. Chem. 1996, 271, 10697-703. (Pubitemid 26145805)
8. Hotta, K.; Funahashi, T.; Arita, Y.; Takahashi, M.; Matsuda, M.; Okamoto, Y.; Iwahashi, H.; Kuriyama, H.; Ouch,i N.; Maeda, K.; Nishida, M.; Kihara, S.; Sakai, N.; Nakajima, T.; Hasegawa, K.; Muraguchi, M.; Ohmoto, Y.; Nakamura, T.; Yamashita, S.; Hanafusa, T.; Matsuzawa, Y. Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1595-9. (Pubitemid 30353893)
9. Hulthe, J.; Hultén, L.M.; Fagerberg, B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism, 2003, 52, 1612-4. (Pubitemid 38049281)
10. Ouchi, N.; Kihara, S.; Arita, Y.; Maeda, K.; Kuriyama, H.; Okamoto, Y.; Hotta, K.; Nishida, M.; Takahashi, M.; Nakamura, T.; Yamashita, S.; Funahashi, T.; Matsuzawa, Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100, 2473-6. (Pubitemid 30005109)
11. Ryo, M.; Nakamura, T.; Kihara, S.; Kumada, M.; Shibazaki, S.; Takahashi, M.; Nagai, M.; Matsuzawa, Y;, Funahashi, T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J., 2004, 68, 975-81. (Pubitemid 39540124)
12. Grundy, S.M.; Brewer, H.B. Jr.; Cleeman, J.I.; Smith, S.C. Jr.; Lenfant, C.; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 2004, 109, 433-8. (Pubitemid 38133916)
13. Hotta, K.; Funahashi, T.; Bodkin, N.L.; Ortmeyer, H.K.; Arita, Y.; Hansen, B.C.; Matsuzawa, Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes, 2001, 50, 1126-33. (Pubitemid 32374544)
14. Berg, A.H., Combs, T.P., Du, X., Brownlee, M., Scherer, P.E. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-53. (Pubitemid 32756433)
15. Fruebis, J.; Tsao, T.S.; Javorschi, S.; Ebbets-Reed, D.; Erickson, M.R.; Yen, F.T.; Bihain, B.E.; Lodish, H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA, 2001, 98, 2005-10. (Pubitemid 32165613)
16. Yamauchi, T.; Kamon, J.; Waki, H.; Terauchi, Y.; Kubota, N.; Hara, K.; Mori, Y.; Ide, T.; Murakami, K.; Tsuboyama-Kasaoka, N.; Ezaki, O.; Akanuma, Y.; Gavrilova, O.; Vinson, C.; Reitman, M.L.; Kagechika, H.; Shudo, K.; Yoda, M.; Nakano, Y.; Tobe, K.; Nagai, R.; Kimura, S.; Tomita, M.; Froguel, P.; Kadowaki, T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7, 941-6. (Pubitemid 32756432)
17. Yamauchi, T.; Kamon, J.; Waki, H.; Imai, Y.; Shimozawa ,N.; Hioki, K.; Uchida, S.; Ito, Y.; Takakuwa, K.; Matsui, J.; Takata, M.; Eto, K.; Terauchi, Y.; Komeda, K.; Tsunoda, M.; Murakami, K.; Ohnishi, Y.; Naitoh, T.; Yamamura, K.; Ueyama, Y.; Froguel, P.; Kimura, S.; Nagai, R.; Kadowaki, T. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 2003, 278, 2461-8. (Pubitemid 36801322)
18. Kubota, N.; Terauchi, Y.; Yamauchi, T.; Kubota, T.; Moroi, M.; Matsui, J.; Eto, K.; Yamashita, T.; Kamon, J.; Satoh, H.; Yano, W.; Froguel, P.; Nagai, R.; Kimura, S.; Kadowaki, T.; Noda, T. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem., 2002, 277, 25863-6. (Pubitemid 34967064)
19. Maeda, N.; Shimomura, I.; Kishida, K.; Nishizawa, H.; Matsuda ,M.; Nagaretani, H.; Furuyama, N.; Kondo, H.; Takahashi, M.; Arita, Y.; Komuro, R.; Ouchi, N.; Kihara, S.; Tochino, Y.; Okutomi, K.; Horie, M.; Takeda, S.; Aoyama, T.; Funahashi, T.; Matsuzawa, Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8, 731-7. (Pubitemid 34778727)
20. Scherer, P.E.; Williams, S.; Fogliano, M.; Baldini, G.; Lodish, H.F.; A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995, 270, 26746-9.
21. Maeda, N.; Takahashi, M.; Funahashi, T.; Kihara, S.; Nishizawa, H.; Kishida, K.; Nagaretani, H.; Matsuda, M.; Komuro, R.; Ouchi, N.; Kuriyama, H.; Hotta, K.; Nakamura, T.; Shimomura, I.; Matsuzawa, Y. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001, 50, 2094-9. (Pubitemid 33643677)
22. Combs, T.P.; Wagner, J.A.; Berger, J.; Doebber, T.; Wang, W.J.; Zhang, B.B.; Tanen, M.; Berg, A.H.; O'Rahilly, S.; Savage, D.B.; Chatterjee, K.; Weiss, S.; Larson, P.J.; Gottesdiener, K.M.; Gertz, B.J.; Charron, M.J.; Scherer, P.E.; Moller, D.E. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization. Endocrinology, 2002, 143, 998-1007. (Pubitemid 34164048)
23. Bouaboula, M.; Hilairet, S.; Marchand, J.; Fajas, L.; Le Fur, G.; Casellas, P. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur. J. Pharmacol. 2005, 517, 174-81. (Pubitemid 40977892)
24. Fukuen, S.; Iwaki, M.; Yasui, A.; Makishima, M.; Matsuda, M.; Shimomura, I. Sulfonylurea agents exhibit peroxisome proliferatoractivated receptor γ agonistic activity. J. Biol. Chem. 2005, 280, 23653-9. (Pubitemid 40884846)
25. Shin, D.W.; Kim, S.N.; Lee, S.M.; Lee, W.; Song, M.J.; Park, S.M.; Lee, T.R.; Baik, J.H.; Kim, H.K.; Hong, J.H.; Noh, M. (-)- Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation. Biochem. Pharmacol. 2009, 77, 125-33.
26. Kunimasa, K.; Kuranuki, S.; Matsuura, N.; Iwasaki, N.; Ikeda, M.; Ito, A.; Sashida, Y.; Mimaki, Y.; Yano, M.; Sato, M.; Igarashi, Y.; Oikawa, T. Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion. Bioorg. Med. Chem. Lett. 2009, 19, 2062-4.
27. Hiragun, A.; Sato, M.; Mitsui, H. Establishment of a clonal cell line that differentiates into adipose cells in vitro. In Vitro, 1980, 16, 685-93. (Pubitemid 11255692)
28. Sato, M.; Yajima, Y.; Kawashima, S.; Tanaka, K.; Kagechika, H. Synergistic potentiation of thiazolidinedione-induced ST13 preadipocyte differentiation by RXR synergists. Biochem. Biophys. Res. Commun. 2001, 280, 646-51. (Pubitemid 32924479)
29. Yajima, Y.; Sato, M.; Sumida, M.; Kawashima, S. Mechanism of adult primitive mesenchymal ST-13 preadipocyte differentiation. Endocrinology, 2003, 144, 2559-65. (Pubitemid 36629909)
30. Waki, H.; Yamauchi, T.; Kamon, J.; Ito, Y.; Uchida, S.; Kita, S.; Hara, K.; Hada, Y.; Vasseur, F.; Froguel, P.; Kimura, S.; Nagai, R.; Kadowaki, T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 2003, 278, 40352-63. (Pubitemid 37248604)
31. Okamoto, Y.; Kihara, S.; Ouchi, N.; Nishida, M.; Arita, Y.; Kumada, M.; Ohashi, K.; Sakai, N.; Shimomura, I.; Kobayashi, H.; Terasaka, N.; Inaba, T.; Funahashi, T.; Matsuzawa, Y. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 2002, 106, 2767-70. (Pubitemid 35396973)
32. Kubota, N.; Terauchi, Y.; Kubota, T.; Kumagai, H.; Itoh, S.; Satoh, H.; Yano, W.; Ogata, H.; Tokuyama, K.; Takamoto, I.; Mineyama, T.; Ishikawa, M.; Moroi, M.; Sugi, K.; Yamauchi, T.; Ueki, K.; Tobe, K.; Noda, T.; Nagai, R.; Kadowaki, T. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J. Biol. Chem. 2006, 281, 8748-55. (Pubitemid 43847980)
33. Waki, H.; Park, K.W.; Mitro, N.; Pei, L.; Damoiseaux, R.; Wilpitz, D.C.; Reue, K.; Saez, E.; Tontonoz, P. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression. Cell Metab. 2007, 5, 357-70. (Pubitemid 46667757)
34. Tsuda, T.; Ueno, Y.; Aoki, H.; Koda, T.; Horio, F.; Takahashi, N.; Kawada, T.; Osawa, T. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 2004, 316, 149-57. (Pubitemid 38304941)
35. Moriuchi, A.; Yamasaki, H.; Shimamura, M.; Kita, A.; Kuwahara, H.; Fujishima, K.; Satoh, T.; Fukushima, K.; Fukushima, T.; Hayakawa, T.; Mizuguchi, H.; Nagayama, Y.; Abiru, N.; Kawasaki, E.; Eguchi, K. Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPARgamma activation. Biochem. Biophys. Res. Commun. 2007, 356, 1024-30. (Pubitemid 46529394)
36. Zhang, H.; Matsuda, H.; Yamashita, C.; Nakamura, S.; Yoshikawa, M. Hydrangeic acid from the processed leaves of Hydrangea macrophylla var. thunbergii as a new type of anti-diabetic compound. Eur. J. Pharmacol. 2009, 606, 255-61.
37. Yamazaki, Y.; Kawano, Y.; Uebayasi, M. Induction of adiponectin by natural and synthetic phenolamides in mouse and human preadipocytes and its enhancement by docosahexaenoic acid. Life Sci. 2008, 82, 290-300.
38. Kuroyanagi, K.; Kang, M.S.; Goto, T.; Hirai, S.; Ohyama, K.; Kusudo, T.; Yu, R.; Yano, M.; Sasaki, T.; Takahashi, N.; Kawada, T. Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2008, 366, 219-25. (Pubitemid 50007730)
39. Horiba, T.; Nishimura, I.; Nakai, Y.; Abe, K.; Sato, R. Naringenin chalcone improves adipocyte functions by enhancing adiponectin production. Mol. Cell. Endocrinol. 2010, 323, 208-14.
40. Suzuki, O.; Katsumata, Y.; Oya, M.; Chari, V.M.; Vermes, B.; Wagner, H.; Hostettmann, K. Inhibition of type a and type B monoamine oxidases by naturally occurring xanthones. Planta Med., 1981, 42, 17-21. (Pubitemid 11077169)
41. Fotie, J.; Nkengfack, A.E.; Rukunga, G.; Tolo, F.; Peter, M.G.; Heydenreich, M.; Fomum, Z.T. In-vivo antimalarial activity of some oxygenated xanthones. Ann. Trop. Med. Parasitol. 2003, 97, 683-8. (Pubitemid 37468133)
42. Bumrungpert, A.; Kalpravidh, R.W.; Chitchumroonchokchai, C.; Chuang, C.C.; West, T.; Kennedy, A.; McIntosh, M. Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes. J. Nutr. 2009, 139, 1185-91.
43. Nesto, R.W.; Bell, D.; Bonow, R.O.; Fonseca, V.; Grundy, S.M.; Horton, E.S.; Le Winter, M.; Porte, D.; Semenkovich, C.F.; Smith, S.; Young, L.H.; Kahn, R.; American Heart Association; American Diabetes Association. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation, 2003, 108, 2941-8. (Pubitemid 37517824)
44. Matsuzawa, Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580, 2917-21. (Pubitemid 43729162)
45. Tang, W.H.; Maroo, A. PPARgamma agonists: safety issues in heart failure. Diabetes. Obes. Metab. 2007, 9, 447-54. (Pubitemid 47018508)
46. Hiragun, A.; Sato, M.; Mitsui, H. Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent. J. Cell Physiol. 1988, 134, 124-30. (Pubitemid 18034938)
47. Cheung, K.J.; Tzameli, I.; Pissios, P.; Rovira, I.; Gavrilova, O.; Ohtsubo, T.; Chen, Z.; Finkel, T.; Flier, J.S.; Friedman, J.M. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab. 2007, 5, 115-28. (Pubitemid 46187493)
48. Sato, M.; Hiragun, A.; Mitsui, H. Preadipocytes possess cellular retinoid binding proteins and their differentiation is inhibited by retinoids. Biochem. Biophys. Res. Commun. 1980, 95, 1839-45. (Pubitemid 11254325)
49. Lehmann, J.M.; Moore, L.B.; Smith-Oliver, T.A.; Wilkison, W.O.; Willson, T.M.; Kliewer, S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 1995, 270, 12953-6.
50. Sato, M.; Tai, T.; Nunoura, Y.; Yajima, Y.; Kawashima, S.; Tanaka, K. Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol. Pharm. Bull. 2002, 25, 81-6.